AffyImmune Therapeutics Announces Hiring of Dr. Sonal Gupta as Senior Vice President and Head of Clinical Development
NATICK, Mass., April 25, 2022 /PRNewswire/ -- AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid cancers, announced today the addition of Sonal Gupta, MD, PhD to its senior leadership team as Senior Vice President and Head of Clinical Development.
- NATICK, Mass., April 25, 2022 /PRNewswire/ -- AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid cancers, announced today the addition of Sonal Gupta, MD, PhD to its senior leadership team as Senior Vice President and Head of Clinical Development.
- "As immuno-oncology continues to rapidly evolve, we are delighted to welcome a clinician as talented and experienced as Sonal to Affy," said Matt Britz, President.
- "Her oversight of our clinical and pipeline programs and passion for bringing new and innovative therapies to patients with solid tumors will strengthen Affy's Tune & Track platform and our senior leadership team."
- Dr. Gupta added, "I am excited to join a company as vibrant and innovative as AffyImmune.